Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice

Conclusion: Together, our data presented a novel role for VDRA and ACEI in reducing factors associated with CHD that may lead to the discovery of new therapeutic venues.
Source: Therapeutic Advances in Cardiovascular Disease - Category: Cardiology Authors: Tags: Original Research Source Type: research